These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8540738)

  • 1. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis.
    Cabellos C; Martinez-Lacasa J; Martos A; Tubau F; Fernández A; Viladrich PF; Gudiol F
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2158-60. PubMed ID: 8540738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
    Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules.
    Vivas M; Force E; El Haj C; Tubau F; Ariza J; Cabellos C
    J Microbiol Immunol Infect; 2017 Aug; 50(4):435-439. PubMed ID: 26452467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    París MM; Hickey SM; Uscher MI; Shelton S; Olsen KD; McCracken GH
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1320-4. PubMed ID: 8092832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
    Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Fernàndez A; Maiques JM; Tubau F; Ardanuy C; Viladrich PF; Liñares J; Gudiol F
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1907-11. PubMed ID: 12760866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.
    Martínez-Lacasa J; Cabellos C; Martos A; Fernández A; Tubau F; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2002 Mar; 49(3):507-13. PubMed ID: 11864951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
    J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
    Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
    J Antimicrob Chemother; 2000 Jan; 45(1):63-8. PubMed ID: 10629014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.
    Gerber CM; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):866-70. PubMed ID: 10691197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.
    Destache CJ; Pakiz CB; Dash AK; Larsen C
    Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone.
    Egermann U; Stanga Z; Ramin A; Acosta F; Stucki A; Gerber P; Cottagnoud M; Cottagnoud P
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3030-3. PubMed ID: 19364870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.
    Suntur BM; Yurtseven T; Sipahi OR; Buke C; Buke M
    Int J Antimicrob Agents; 2005 Sep; 26(3):258-60. PubMed ID: 16099624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin Should Be Part of Empiric Therapy for Suspected Bacterial Meningitis.
    Olarte L
    J Pediatric Infect Dis Soc; 2019 May; 8(2):187-188. PubMed ID: 30496558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a triple-drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis.
    Lee H; Song JH; Kim SW; Oh WS; Jung SI; Kiem S; Peck KR; Lee NY
    Int J Antimicrob Agents; 2004 Mar; 23(3):307-10. PubMed ID: 15164975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality indicators in pneumococcal meningitis: therapeutic implications.
    Erdem H; Elaldi N; Öztoprak N; Sengoz G; Ak O; Kaya S; Inan A; Nayman-Alpat S; Ulu-Kilic A; Pekok AU; Gunduz A; Gozel MG; Pehlivanoglu F; Yasar K; Yılmaz H; Hatipoglu M; Cicek-Senturk G; Akcam FZ; Inkaya AC; Kazak E; Sagmak-Tartar A; Tekin R; Ozturk-Engin D; Ersoy Y; Sipahi OR; Guven T; Tuncer-Ertem G; Alabay S; Akbulut A; Balkan II; Oncul O; Cetin B; Dayan S; Ersoz G; Karakas A; Ozgunes N; Sener A; Yesilkaya A; Erturk A; Gundes S; Karabay O; Sirmatel F; Tosun S; Turhan V; Yalci A; Akkoyunlu Y; Aydın E; Diktas H; Kose S; Ulcay A; Seyman D; Savasci U; Leblebicioglu H; Vahaboglu H
    Int J Infect Dis; 2014 Feb; 19():13-9. PubMed ID: 24211227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis.
    Vivas M; Force E; Garrigós C; Tubau F; Platteel AC; Ariza J; Cabellos C
    J Antimicrob Chemother; 2014 Nov; 69(11):3020-6. PubMed ID: 24962033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.
    Rodriguez-Cerrato V; Ghaffar F; Saavedra J; Michelow IC; Hardy RD; Iglehart J; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3098-103. PubMed ID: 11600362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.